Cargando…
Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752286/ https://www.ncbi.nlm.nih.gov/pubmed/29988078 http://dx.doi.org/10.1038/s41436-018-0099-0 |
Sumario: |
---|